Related Experiment Video
Updated: Jun 4, 2026
07:12
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Network analysis of clinical trials on depression: implications for comparative effectiveness research
Suresh K Bhavnani1, Simona Carini, Jessica Ross
1Center for Computational Medicine & Bioinformatics.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|February 25, 2011
Summary
Network analysis of clinical trial data reveals intervention patterns for depression treatments. This approach aids in understanding current research and categorizing therapies for better clinical care and future trial design.
Area of Science:
- Clinical Informatics
- Network Science
- Psychiatry
Background:
- Understanding treatment evidence is crucial for clinical care and trial design.
- Comprehending complex intervention combinations across trials is challenging.
- Limited search tools in databases like ClinicalTrials.gov hinder evidence synthesis.
Purpose of the Study:
- To demonstrate network visualization and quantitative analysis of drug intervention co-occurrence in depression trials.
- To identify general and specific intervention patterns within depression research.
- To develop a graph-theoretic measure for categorizing disease interventions.
Main Methods:
- Utilized network analysis to visualize and quantify co-occurrence of interventions.
- Analyzed data from depression trials registered in ClinicalTrials.gov.
- Applied graph-theoretic principles to categorize interventions.
Main Results:
- Identified overarching co-occurrence patterns of interventions across all depression trials.
- Revealed specific co-occurrence patterns for antidepressants and natural supplements.
- Generated insights into the current landscape of depression clinical trials.
Conclusions:
- Network analysis provides a powerful tool for understanding intervention landscapes in clinical research.
- The developed graph-theoretic measure can categorize interventions for diseases.
- The approach has potential for generalization to analyze comparative interventional studies across various diseases.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.